# Shandong Qilu King-phar Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/shandong-qilu-king-phar-pharmaceutical-co-ltd/6f6df71b-c004-4e18-a7c0-6e5469a8c6b3

> Inspection records and compliance data for Shandong Qilu King-phar Pharmaceutical Co., Ltd. in Jinan, None. Access full analysis and detailed observations.

---

## Details

- Name: Shandong Qilu King-phar Pharmaceutical Co., Ltd.
- FEI Number: 3003657816
- City: Jinan
- State: None
- Country Name: China
- Address Line 1: No. 21 Qinglong Road, Pingyin
- Zip Code: None

## Related Documents

- [FDA Inspection 1220963 - Shandong Qilu King-phar Pharmaceutical Co., Ltd. - 2023-09-15](https://www.keypedia.com/records/fda_inspections/shandong-qilu-king-phar-pharmaceutical-co-ltd/d75c788e-0a02-4de6-a4cf-001c5de4cd8b) — classification: No Action Indicated (NAI), source: FDA, date: September 15, 2023
- [FDA Inspection 1009139 - Shandong Qilu King-phar Pharmaceutical Co., Ltd. - 2017-03-24](https://www.keypedia.com/records/fda_inspections/shandong-qilu-king-phar-pharmaceutical-co-ltd/9933b0c8-311d-46d3-a859-8629265cc899) — classification: No Action Indicated (NAI), source: FDA, date: March 24, 2017
- [FDA Inspection 928475 - Shandong Qilu King-phar Pharmaceutical Co., Ltd. - 2015-04-24](https://www.keypedia.com/records/fda_inspections/shandong-qilu-king-phar-pharmaceutical-co-ltd/64621be8-9ad4-401b-b884-7b52c2c2faba) — classification: No Action Indicated (NAI), source: FDA, date: April 24, 2015
- [FDA Inspection 738711 - Shandong Qilu King-phar Pharmaceutical Co., Ltd. - 2011-08-04](https://www.keypedia.com/records/fda_inspections/shandong-qilu-king-phar-pharmaceutical-co-ltd/36bb6702-b48b-41e2-8949-e774d49ff233) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 4, 2011
- [FDA Inspection 738711 - Shandong Qilu King-phar Pharmaceutical Co., Ltd. - 2011-08-04](https://www.keypedia.com/records/fda_inspections/shandong-qilu-king-phar-pharmaceutical-co-ltd/5ecf671a-1c84-4070-8b73-656a55613c92) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 4, 2011
- [FDA Inspection 738711 - Shandong Qilu King-phar Pharmaceutical Co., Ltd. - 2011-08-04](https://www.keypedia.com/records/fda_inspections/shandong-qilu-king-phar-pharmaceutical-co-ltd/2000ed22-ff1b-4d3f-b834-bf67b678636e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 4, 2011

## Related Companies

- [Ingredion Incorporated](https://www.keypedia.com/companies/ingredion-incorporated/682134aa-702a-4956-8caa-c79b25f59948)
- [Pfanstiehl, Inc](https://www.keypedia.com/companies/pfanstiehl-inc/970291ff-e456-4b46-b5f5-20c57b331665)
- [BioMimetic Therapeutics, LLC](https://www.keypedia.com/companies/biomimetic-therapeutics-llc/a8a0027c-d16c-42dd-bfe0-22d536602148)
- [Tomita Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/tomita-pharmaceutical-co-ltd/01c2e59a-b579-43f4-a73d-527ad6021b2b)
- [US Salt LLC](https://www.keypedia.com/companies/us-salt-llc/46aa9dcc-39ce-4415-bc25-6da709feb341)
- [Jiangsu Lianhuan Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/jiangsu-lianhuan-pharmaceutical-co-ltd/6ad4f52f-348f-4e7e-9539-7e51d3583927)
- [Fujian Fukang Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/fujian-fukang-pharmaceutical-co-ltd/1cea7fe1-88a5-4b17-9374-cb48d4391f42)
- [Aino Co., Ltd. of North China Pharma. Group](https://www.keypedia.com/companies/aino-co-ltd-of-north-china-pharma-group/e6d7882f-44c2-4550-bbec-b76d137da6f2)
- [Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-apeloa-jiayuan-pharmaceutical-co-ltd/f2f96881-f40f-4bf1-80f8-b610cebf3ac3)
- [Changzhou Qianhong Bio Pharma Co., Ltd. (Formulation Plant)](https://www.keypedia.com/companies/changzhou-qianhong-bio-pharma-co-ltd-formulation-plant/0eaeb34d-138d-4900-b6cd-369306936336)